Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trial
PaperCitations, authors & open-access status
Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 261 citations, 2020 year and closed oa status.
261
Citations
2020
Year
closed
OA Status